JP2025516153A5 - - Google Patents
Info
- Publication number
- JP2025516153A5 JP2025516153A5 JP2024562134A JP2024562134A JP2025516153A5 JP 2025516153 A5 JP2025516153 A5 JP 2025516153A5 JP 2024562134 A JP2024562134 A JP 2024562134A JP 2024562134 A JP2024562134 A JP 2024562134A JP 2025516153 A5 JP2025516153 A5 JP 2025516153A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- disorder
- disease
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2250486 | 2022-04-22 | ||
| SE2250486-4 | 2022-04-22 | ||
| PCT/EP2023/060601 WO2023203248A1 (en) | 2022-04-22 | 2023-04-24 | Subcutaneous administration of an asbt inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516153A JP2025516153A (ja) | 2025-05-27 |
| JP2025516153A5 true JP2025516153A5 (cg-RX-API-DMAC10.html) | 2026-04-23 |
Family
ID=86330799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562134A Pending JP2025516153A (ja) | 2022-04-22 | 2023-04-24 | Ａｓｂｔ阻害剤の皮下投与 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230338392A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4511038A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025516153A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119053330A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023255249A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023203248A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX366925B (es) | 2010-11-04 | 2019-07-31 | Albireo Ab | Inhibidores de ibat para el tratamiento de enfermedades hepaticas. |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| KR20210024033A (ko) | 2018-06-20 | 2021-03-04 | 알비레오 에이비 | 오데빅시바트의 약학 제제 |
| SG11202108566VA (en) | 2019-02-06 | 2021-09-29 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| CA3158195A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP7665621B2 (ja) | 2019-12-04 | 2025-04-21 | アルビレオ・アクチボラグ | ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CN114786772B (zh) | 2019-12-04 | 2024-04-09 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| AU2021379076A1 (en) | 2020-11-12 | 2023-06-08 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| BR112023010799A2 (pt) | 2020-12-04 | 2023-10-03 | Albireo Ab | Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares |
| CN117412955A (zh) | 2021-06-03 | 2024-01-16 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| EP4629997A1 (en) * | 2022-12-09 | 2025-10-15 | Albireo AB | Asbt inhibitors in the treatment of renal diseases |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9203347D0 (en) | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
| TW289020B (cg-RX-API-DMAC10.html) | 1993-05-08 | 1996-10-21 | Hoechst Sktiengesellschaft | |
| TW289021B (cg-RX-API-DMAC10.html) | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
| TW289757B (cg-RX-API-DMAC10.html) | 1993-05-08 | 1996-11-01 | Hoechst Ag | |
| DE04010088T1 (de) | 1996-03-11 | 2005-07-14 | G.D. Searle Llc | Neue Benzothiepine mit pharmazeutischer Wirkung. |
| ATE242258T1 (de) | 1997-03-14 | 2003-06-15 | Aventis Pharma Gmbh | Hypolipidemische 1,4-benzothiazepin-1,1-dioxide |
| SE9901387D0 (sv) | 1999-04-19 | 1999-04-19 | Astra Ab | New pharmaceutical foromaulations |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| MY131995A (en) | 2001-09-08 | 2007-09-28 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with illeal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| GB0201850D0 (en) | 2002-01-26 | 2002-03-13 | Astrazeneca Ab | Therapeutic treatment |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0216321D0 (en) | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
| WO2004020421A1 (ja) | 2002-08-28 | 2004-03-11 | Asahi Kasei Pharma Corporation | 新規な４級アンモニウム化合物 |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| AU2005217318B2 (en) | 2004-02-27 | 2010-07-01 | Asahi Kasei Pharma Corporation | Novel benzothiazepine and benzothiepine compounds |
| DE102005033099A1 (de) | 2005-07-15 | 2007-01-18 | Sanofi-Aventis Deutschland Gmbh | Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung |
| DE102005033100B3 (de) | 2005-07-15 | 2007-01-25 | Sanofi-Aventis Deutschland Gmbh | Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung |
| DE102006053635B4 (de) | 2006-11-14 | 2011-06-30 | Sanofi-Aventis Deutschland GmbH, 65929 | Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| JO3131B1 (ar) | 2010-04-27 | 2017-09-20 | Glaxosmithkline Llc | مركبات كيميائية |
| MX366925B (es) | 2010-11-04 | 2019-07-31 | Albireo Ab | Inhibidores de ibat para el tratamiento de enfermedades hepaticas. |
| JP6217938B2 (ja) | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
| KR101674806B1 (ko) | 2014-10-20 | 2016-11-10 | 씨제이헬스케어 주식회사 | 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도 |
| JP7391048B2 (ja) | 2018-06-05 | 2023-12-04 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| KR20210024033A (ko) * | 2018-06-20 | 2021-03-04 | 알비레오 에이비 | 오데빅시바트의 약학 제제 |
| SG11202108566VA (en) | 2019-02-06 | 2021-09-29 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| CN113453753B (zh) | 2019-02-06 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途 |
| EP4424363B1 (en) * | 2019-02-12 | 2026-04-29 | Mirum Pharmaceuticals, Inc. | Methods for increasing growth in pediatric subjects having cholestatic liver disease |
| CA3158195A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP7665621B2 (ja) | 2019-12-04 | 2025-04-21 | アルビレオ・アクチボラグ | ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CN114786772B (zh) | 2019-12-04 | 2024-04-09 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| WO2021110885A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| ES3002777T3 (en) | 2020-08-03 | 2025-03-07 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| BR112023010799A2 (pt) | 2020-12-04 | 2023-10-03 | Albireo Ab | Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares |
| CN117412955A (zh) | 2021-06-03 | 2024-01-16 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
-
2023
- 2023-04-24 CN CN202380035217.3A patent/CN119053330A/zh active Pending
- 2023-04-24 EP EP23722840.8A patent/EP4511038A1/en active Pending
- 2023-04-24 JP JP2024562134A patent/JP2025516153A/ja active Pending
- 2023-04-24 US US18/138,375 patent/US20230338392A1/en active Pending
- 2023-04-24 WO PCT/EP2023/060601 patent/WO2023203248A1/en not_active Ceased
- 2023-04-24 AU AU2023255249A patent/AU2023255249A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7010836B2 (ja) | 胆汁鬱滞性疾患の処置の方法 | |
| US20230338392A1 (en) | Subcutaneous administration of an asbt inhibitor | |
| Kyriakidis et al. | Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases | |
| KR102000332B1 (ko) | 간내 담즙정체성 질환의 치료 | |
| US20240207286A1 (en) | Asbt inhibitors in the treatment of renal diseases | |
| KR20190015363A (ko) | 간내 담즙 정체성 질환의 치료 | |
| CN113613640B (zh) | 肾上腺素能β2受体激动剂R-对映体在治疗炎症性肠病及其肠外疾病的新应用 | |
| EP4153156A1 (en) | Elafibranor for the treatment of primary sclerosing cholangitis | |
| CN110538181B (zh) | 酪氨酸激酶抑制剂在制备治疗急性肾损伤药物中的应用 | |
| RU2024129910A (ru) | Подкожное введение ингибитора ASBT | |
| Baumann et al. | Effects of the ileal bile acid transport inhibitor A4250 on pruritus and serum bile acids in patients with biliary atresia: phase 2 study results | |
| LAI et al. | Papillary necrosis associated with rifampicin therapy | |
| JP2024503861A (ja) | 慢性腎疾患を処置する方法 | |
| WO2021097027A1 (en) | Seladelpar for use in the treatment of alcoholic liver disease | |
| RU2025113791A (ru) | Ингибиторы ASBT в лечении заболеваний почек | |
| Kimura et al. | The surgical management of the unusual forms of biliary atresia | |
| RU2815160C1 (ru) | Способ профилактики поражения печени при остром панкреатите | |
| JP7596548B2 (ja) | 胆管症の治療 | |
| Pezzilli et al. | Acute pancreatitis associated with myotonic dystrophy type I | |
| Maslonka et al. | Hypertriglyceridemia induced acute pancreatitis associated with diabetic ketoacidosis and a vaginal estrogen contraceptive device (NuvaRing): successfully treated with insulin infusion, plasmapheresis, and ring removal: 1316 | |
| HK40118120A (zh) | 皮下给药asbt抑制剂 | |
| 王小健 | Effect of low expression of PTHrp receptor on proliferation of tibial growth plate chondrocytes in chronic renal insufficiency young rats | |
| John et al. | A Small Volume of Literature on High Volume Post-Obstructive Choleresis-a Rare Diagnosis: 1315 | |
| Bansal et al. | Acute Pancreatitis Following Trans-arterial Chemo-embolization for Hepatocellular Carcinoma: 1314 | |
| HK40128340A (zh) | 治疗肾脏疾病的asbt抑制剂 |